Concepedia

Tamar Goren

TG

Statistics

Publications

7

Citations

500

H-Index

7

Active since

1991

Affiliations

Teva Pharmaceuticals (Israel)(Current)

Hebrew University of Jerusalem

Tamar Goren is an author at Teva Pharmaceuticals (Israel) specializing in medicine, neurology, and neuropharmacology.

Top concepts

Publications per year

1991–2010

7

Publications

7

Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer's Disease

Jeffrey Sterling, Yaacov Herzig, Tamar Goren et al. · Journal of Medicinal Chemistry · 2002 · 251 citations · Full text

, , +19

Rasagiline improves quality of life in patients with early Parkinson's disease

Kevin Biglan, Steven Schwid, Shirley Eberly et al. · Movement Disorders · 2006 · 66 citations

, , +11

Development of a novel neuroprotective drug (TV3326) for the treatment of Alzheimer's disease, with cholinesterase and monoamine oxidase inhibitory activities

Marta Weinstock, Tamar Goren, Moussa B. H. Youdim · Drug Development Research · 2000 · 56 citations

Clinical Pharmacology Tyramine Challenge Study to Determine the Selectivity of the Monoamine Oxidase Type B (MAO‐B) Inhibitor Rasagiline

Tamar Goren, Liat Adar, Yoni M. Weiss · The Journal of Clinical Pharmacology · 2010 · 40 citations

, , +12

Long-Term Efficacy of Rasagiline in Early Parkinson's Disease

Mark Lew, Robert A. Hauser, Howard I. Hurtig et al. · International Journal of Neuroscience · 2010 · 33 citations

Rows per page

1–5 of 7